Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$273.7M
-2.2% from 2023
Prescriptions
49K
$5,630.26 per claim
Patients
6,685
4,892 prescribers
Total spending, 2024
$273.8M
$40,944.63 per patient
Medicare prescription drug plans paid $273.7M for Xeljanz in 2024, for 48,612 prescriptions and refills to 6,685 patients (down 2.2% from 2023). The average cost per claim was $5,630.26.
California had the highest Medicare cost for Xeljanz in 2024: $31.1M for 6,822 claims, followed by New York ($24.2M).
James E Gore, rheumatology in Nashville, TN, had the highest Medicare cost for Xeljanz in 2024: 189 claims costing $1.1M.
Xeljanz is made by Pfizer Inc. (PFE), listed in the Medicare spending data as Pfizer US Pharm.
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| James E Gore Nashville, TN | Rheumatology | 189 | 20 | $1.1M |
| Wilfredo A Villarrubia West Columbia, SC | Physician Assistant | 93 | 21 | $625K |
| James C Byrd |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 5,403 | 53,847 | 7,974 | $295.3M |
| 2023 | 4,980 | 49,551 | 6,932 | $279.9M |
| 2024 | 4,892 | 48,612 | 6,685 | $273.7M |
Amount reimbursed by state Medicaid programs, all states
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Rheumatology |
| 96 |
| 11 |
| $592K |
| Ya Ju Chang New York, NY | Rheumatology | 101 | 11 | $587K |
| Luisana Gomez Monterey Park, CA | Physician Assistant | 109 | 21 | $586K |
| Patrick K Timms Pueblo, CO | Rheumatology | 98 | 14 | $575K |
| Jennifer Burkham San Jose, CA | Rheumatology | 103 | 13 | $563K |
| Elvin R Garcia McAllen, TX | Rheumatology | 95 | 13 | $546K |
| Carlos Lorenzo San Antonio, TX | Rheumatology | 89 | 12 | $505K |
| Agnes A Solon Alexandria, LA | Rheumatology | 87 | 14 | $504K |
| Sathish Kumar Itikyala West Plains, MO | Internal Medicine | 79 | 14 | $494K |
| Heena A Birbal Jain Champaign, IL | Internal Medicine | 76 | 12 | $479K |
| Jose M Encarnacion-Cruz Levittown, PR | Rheumatology | 84 | 11 | $473K |
| Farrukh Zaidi Port Richey, FL | Rheumatology | 70 | Under 11 | $469K |
| Barry L Getzoff Langhorne, PA | Rheumatology | 72 | Under 11 | $468K |
| Shirley A Albano Hershey, PA | Rheumatology | 84 | 15 | $460K |
| Kiley Toder Johnston, RI | Rheumatology | 79 | Under 11 | $458K |
| Rupal Chavda Pueblo, CO | Rheumatology | 69 | Under 11 | $436K |
| Sathya K Velkuru Albany, NY | Rheumatology | 126 | 22 | $436K |
| Sharon Kolasinski Philadelphia, PA | Rheumatology | 75 | Under 11 | $434K |
| James M Lawrence Mobile, AL | Family Practice | 70 | 12 | $412K |
| Ralph W Webb Huntington, WV | Rheumatology | 63 | Under 11 | $409K |
| Kristine B Alix Queensbury, NY | Nurse Practitioner | 59 | Under 11 | $400K |
| David R Finger Honolulu, HI | Rheumatology | 135 | 18 | $396K |
| Kathy C Lynn Macon, GA | Rheumatology | 46 | Under 11 | $391K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Pfizer US Pharm PFE | 48,637 | $273.8M |